This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Durus Manager Gets Hard Time

Scott Sacane, the disgraced hedge fund manager who claimed to have mistakenly accumulated a controlling stake in a tiny biotech company, is going to jail.

A U.S. judge sentenced Sacane on Tuesday to three years in federal prison. Sacane pleaded guilty in December 2005 to charges that he manipulated shares of two small biotech companies, Esperion and Aksys, by failing to disclose that his hedge fund had purchased huge equity stakes in both companies.

Sacane's sentencing comes nearly four years after his hedge fund, once worth $500 million, belatedly disclosed that it had amassed a 77% ownership stake in Aksys, a dialysis machine manufacturer, and a 33% stake in Esperion, a drug manufacturer.

Sacane initially said the fund "inadvertently" became the biggest shareholder in both companies, and denied doing anything wrong. He never explained, however, why Durus continued to keep buying shares even after cutting agreements with Aksys and Esperion to halt the purchases.

Aksys was delisted from Nasdaq in December and recently fetched 9 cents a share on the over-the-counter bulletin board. Esperion was purchased in 2004 by Pfizer (PFE).

Sacane's bizarre defense never seemed credible, and most on Wall Street believed he was trying to manipulate the stock price of the two companies in order to inflate his hedge fund's returns.

"This prosecution and the term of imprisonment imposed today should send a strong message to hedge fund managers," says Connecticut U.S. Attorney Kevin O'Connor.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs